Trials Sponsors Conditions Drugs Pricing

Conditions

Herpes Simplex Herpes Zoster Varicella Zoster

Keywords

Methylene blueGiemsaTzanck smear

Outcome Measures

Primary Outcomes (1)

Sensitivity
Positive results from staining compared with number of cases
24 weeks

Secondary Outcomes (2)

Factors that contribute the results from Methylene blue staining
24 weeks
Specificity
24 weeks

Study Arms (2)

Case

ACTIVE COMPARATOR

Patients who clinically diagnosed as herpes simplex, herpes zoster or varicella zoster skin infection.

Diagnostic Test: Methylene blueDiagnostic Test: Giemsa stain

Negative control

SHAM COMPARATOR

Patients who develops vesicular lesion but not typically considered as herpesviral skin infection, such as acute eczema, Paederus dermatitis

Diagnostic Test: Methylene blueDiagnostic Test: Giemsa stain

Interventions

Methylene blueDiagnostic test

working solution methylene blue

CaseNegative control

Giemsa stainDiagnostic test

working solution Giemsa stain (Wolbach's modification)

Case

Eligibility Criteria

Age18 Years+

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

patients with clinically suspected of having herpes simplex, herpes zoster, varicella zoster skin infections.
Those who have vesicular skin lesion such as acute eczema, Paederus dermatitis.

Sponsors & Collaborators

Dermatological Society of Thailand
Othercollaborator
Chulalongkorn University
Otherlead

Study Sites (1)

Division of Dermatology, Faculty of Medicine, Chulalongkorn University

Bangkok, 10330, Thailand

RECRUITING

Pawinee Rerknimitr, MD, MScCONTACT+6622564253 pawinee.r@chula.ac.th

Kittipong Wantavornprasert, MDSUB INVESTIGATOR

Pokrath Hansasuta, MD, PhDSUB INVESTIGATOR

MeSH Terms

Conditions

Herpes SimplexHerpes Zoster

Condition Hierarchy (Ancestors)

Herpesviridae InfectionsDNA Virus InfectionsVirus DiseasesInfectionsSkin Diseases, ViralSkin Diseases, InfectiousSkin DiseasesSkin and Connective Tissue DiseasesVaricella Zoster Virus Infection

Study Officials

Pawinee Rerknimitr, MD, MSc
Chulalongkorn University
PRINCIPAL INVESTIGATOR

Central Study Contacts

Pawinee Rerknimitr, MD, MSc

CONTACT

+6622564253 pawinee.r@chula.ac.th

Study Design

Study Type: interventional
Phase: phase 3
Allocation: NON RANDOMIZED
Masking: QUADRUPLE
Who Masked: PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose: DIAGNOSTIC
Intervention Model: PARALLEL
Sponsor Type: OTHER
Responsible Party: PRINCIPAL INVESTIGATOR
PI Title: Assistant professor

Study Record Dates

First Submitted

June 2, 2017

First Posted

June 7, 2017

Study Start

March 7, 2017

Actual (reported)

Primary Completion

December 7, 2017

Estimated (date passed)

Tzanck Smear With Methylene Blue Stain for Herpes

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (2)

Study Arms (2)

Case

Negative control

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Central Study Contacts

Study Design

Study Record Dates

You may not qualify if:

Data Sharing

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (2)

Study Arms (2)

Case

Negative control

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Central Study Contacts

Study Design

Study Record Dates

You may not qualify if:

Data Sharing

Source record

Locations